BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

782 related articles for article (PubMed ID: 21069266)

  • 1. The Wnt5a/Ror2 noncanonical signaling pathway inhibits canonical Wnt signaling in K562 cells.
    Yuan Y; Niu CC; Deng G; Li ZQ; Pan J; Zhao C; Yang ZL; Si WK
    Int J Mol Med; 2011 Jan; 27(1):63-9. PubMed ID: 21069266
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myeloma cells inhibit non-canonical wnt co-receptor ror2 expression in human bone marrow osteoprogenitor cells: effect of wnt5a/ror2 pathway activation on the osteogenic differentiation impairment induced by myeloma cells.
    Bolzoni M; Donofrio G; Storti P; Guasco D; Toscani D; Lazzaretti M; Bonomini S; Agnelli L; Capocefalo A; Dalla Palma B; Neri A; Nicolini F; Lisignoli G; Russo F; Colla S; Aversa F; Giuliani N
    Leukemia; 2013 Feb; 27(2):451-63. PubMed ID: 22781592
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Wnt5a induces homodimerization and activation of Ror2 receptor tyrosine kinase.
    Liu Y; Rubin B; Bodine PV; Billiard J
    J Cell Biochem; 2008 Oct; 105(2):497-502. PubMed ID: 18615587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of Ror2 and Wnt5a expression in medulloblastoma.
    Lee SE; Lim SD; Kang SY; Suh SB; Suh YL
    Brain Pathol; 2013 Jul; 23(4):445-53. PubMed ID: 23278988
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Wnt5a-Ror2 signaling between osteoblast-lineage cells and osteoclast precursors enhances osteoclastogenesis.
    Maeda K; Kobayashi Y; Udagawa N; Uehara S; Ishihara A; Mizoguchi T; Kikuchi Y; Takada I; Kato S; Kani S; Nishita M; Marumo K; Martin TJ; Minami Y; Takahashi N
    Nat Med; 2012 Feb; 18(3):405-12. PubMed ID: 22344299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Purified Wnt5a protein activates or inhibits beta-catenin-TCF signaling depending on receptor context.
    Mikels AJ; Nusse R
    PLoS Biol; 2006 Apr; 4(4):e115. PubMed ID: 16602827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ror-family receptor tyrosine kinases in noncanonical Wnt signaling: their implications in developmental morphogenesis and human diseases.
    Minami Y; Oishi I; Endo M; Nishita M
    Dev Dyn; 2010 Jan; 239(1):1-15. PubMed ID: 19530173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insight into the role of Wnt5a-induced signaling in normal and cancer cells.
    Endo M; Nishita M; Fujii M; Minami Y
    Int Rev Cell Mol Biol; 2015; 314():117-48. PubMed ID: 25619716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epigenetic identification of receptor tyrosine kinase-like orphan receptor 2 as a functional tumor suppressor inhibiting β-catenin and AKT signaling but frequently methylated in common carcinomas.
    Li L; Ying J; Tong X; Zhong L; Su X; Xiang T; Shu X; Rong R; Xiong L; Li H; Chan AT; Ambinder RF; Guo Y; Tao Q
    Cell Mol Life Sci; 2014 Jun; 71(11):2179-92. PubMed ID: 24158497
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Canonical and non-canonical Wnt signaling are simultaneously activated by Wnts in colon cancer cells.
    Flores-Hernández E; Velázquez DM; Castañeda-Patlán MC; Fuentes-García G; Fonseca-Camarillo G; Yamamoto-Furusho JK; Romero-Avila MT; García-Sáinz JA; Robles-Flores M
    Cell Signal; 2020 Aug; 72():109636. PubMed ID: 32283254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ror2 receptor requires tyrosine kinase activity to mediate Wnt5A signaling.
    Mikels A; Minami Y; Nusse R
    J Biol Chem; 2009 Oct; 284(44):30167-76. PubMed ID: 19720827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of Wnt5a and Ror2 protein in hepatocellular carcinoma associated with poor prognosis.
    Geng M; Cao YC; Chen YJ; Jiang H; Bi LQ; Liu XH
    World J Gastroenterol; 2012 Mar; 18(12):1328-38. PubMed ID: 22493546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autonomous regulation of osteosarcoma cell invasiveness by Wnt5a/Ror2 signaling.
    Enomoto M; Hayakawa S; Itsukushima S; Ren DY; Matsuo M; Tamada K; Oneyama C; Okada M; Takumi T; Nishita M; Minami Y
    Oncogene; 2009 Sep; 28(36):3197-208. PubMed ID: 19561643
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ror2/Frizzled complex mediates Wnt5a-induced AP-1 activation by regulating Dishevelled polymerization.
    Nishita M; Itsukushima S; Nomachi A; Endo M; Wang Z; Inaba D; Qiao S; Takada S; Kikuchi A; Minami Y
    Mol Cell Biol; 2010 Jul; 30(14):3610-9. PubMed ID: 20457807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Negative regulation of Wnt signaling mediated by CK1-phosphorylated Dishevelled via Ror2.
    Witte F; Bernatik O; Kirchner K; Masek J; Mahl A; Krejci P; Mundlos S; Schambony A; Bryja V; Stricker S
    FASEB J; 2010 Jul; 24(7):2417-26. PubMed ID: 20215527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Wnt5a mediated canonical Wnt signaling pathway activation in orthodontic tooth movement: possible role in the tension force-induced bone formation.
    Fu HD; Wang BK; Wan ZQ; Lin H; Chang ML; Han GL
    J Mol Histol; 2016 Oct; 47(5):455-66. PubMed ID: 27456852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Filopodia formation mediated by receptor tyrosine kinase Ror2 is required for Wnt5a-induced cell migration.
    Nishita M; Yoo SK; Nomachi A; Kani S; Sougawa N; Ohta Y; Takada S; Kikuchi A; Minami Y
    J Cell Biol; 2006 Nov; 175(4):555-62. PubMed ID: 17101698
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Wnt5a modulates glycogen synthase kinase 3 to induce phosphorylation of receptor tyrosine kinase Ror2.
    Yamamoto H; Yoo SK; Nishita M; Kikuchi A; Minami Y
    Genes Cells; 2007 Nov; 12(11):1215-23. PubMed ID: 17986005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stable genetic alterations of β-catenin and ROR2 regulate the Wnt pathway, affect the fate of MSCs.
    Cai SX; Liu AR; He HL; Chen QH; Yang Y; Guo FM; Huang YZ; Liu L; Qiu HB
    J Cell Physiol; 2014 Jun; 229(6):791-800. PubMed ID: 24590964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The orphan tyrosine kinase receptor, ROR2, mediates Wnt5A signaling in metastatic melanoma.
    O'Connell MP; Fiori JL; Xu M; Carter AD; Frank BP; Camilli TC; French AD; Dissanayake SK; Indig FE; Bernier M; Taub DD; Hewitt SM; Weeraratna AT
    Oncogene; 2010 Jan; 29(1):34-44. PubMed ID: 19802008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.